Constant hair loss in the form of gradual thinning of hair, receding hair line, patchy bald spots, excessive loosening of hair leads to baldness which can have a deep negative impact on a person’s self-esteem. People suffering from baldness usually lead a poorer quality of life, have a poorer body image, have an identity crisis, experience anxiety disorder, social phobia and also paranoid disorder.
Baldness can be permanently solved by subjecting the person to a hair transplant. But it is an expensive solution. Topical solutions can also be used for this purpose, but they provide inconsistent results or growth rates.
Hair loss is usually caused by heredity, hormonal changes due to childbirth, pregnancy, thyroid problems, menopause, and other medical conditions. It can also be a side effect of drugs associated with curing of medical ailments such as cancer, arthritis, depression, high blood pressure levels, and heart problems.
A recent study released in the month of May of 2018 brought a possible revolutionary treatment to the limelight and changed the way in which scientists think. This treatment is based on a drug used to fight Osteoporosis.
The result of this study was published in the journal of PLOS biology.
Lab tests were conducted by the researchers from the University of Manchester’s Centre for Dermatology Research. Scalp hair follicles samples collected from around 40 male patients was used in this test.
The drug was tested on these 40 samples by placing them in a medium. At the end of the test, results obtained showed growth of the hair follicles as the SFRP1 actions were curbed by the aforementioned drug.
Kaminska claimed that it is an exciting result and further research has to be done to make any solid conclusions regarding the long term results of this drug on hair fall.
A single drug to cure Osteoporosis and to cure baldness sounds phenomenal and is bound to open up a new branch of study altogether.